Association of Tissue Factor Polymorphism with Fibrinolysis and Excessive Bleeding after Open Heart Surgery - A preliminary report -

Fibrinolysis, which commonly occurs following cardiopulmonary bypass (CPB), may be related to the excessive bleeding (EB) and morbidity after CPB. It is known that tissue factor (TF), which is triggered by CPB, plays an important role in the initiation of fibrinolysis during and after CPB, however, EB and fibrinolysis after CPB show inter-individual variance. Therefore, in this study, TF -603A/G polymorphism was evaluated to determine if it is associated with fibrinolysis and/or EB and morbidity following CPB. Methods: RT-PCR was used to determine the TF genotype of each patient. In addition, the amount of blood loss that occurred during the first 24 hours following surgery was documented, and EB was diagnosed when more than 1 L of blood was lost during the first 24 hours following surgery. The D-dimer levels were measured at; a) Time 1; prior to initiation of CPB, b) Time 2; 2 hours after CPB, and c) Time 3; 24 hours after CPB. The oxygen index (OI) was calculated at; 1) OI1; upon admission to the ICU, b) OI2; 24 hrs after admission to the ICU, and c) OI3; 48 hrs after admission to the ICU. The intubation time and the length of the ICU stay were also documented. Results: The serum D-Dimer level of the TF -603AA group (n = 72) measured at time 3 was higher than that of the TF -603GG/GA group (n = 25) measured at the same time. In addition, the incidence of EB and the intubation time of the TF -603AA group were higher than those of the TF -603GG/GA group. Finally, the OI3 of the TF -603AA group was lower than that of the TF -603GG/GA group. Conclusions: The G allele that is associated with TF -603A/G polymorphism may be protective against fibrinolysis following CPB, therefore, it may also be protective against EB and morbidity following CPB.

[1]  R. Whitlock,et al.  Bleeding in cardiac surgery: its prevention and treatment--an evidence-based review. , 2005, Critical care clinics.

[2]  M. Newman,et al.  Genetic factors contribute to bleeding after cardiac surgery , 2005, Journal of thrombosis and haemostasis : JTH.

[3]  I. Bièche,et al.  The TF-603A/G gene promoter polymorphism and circulating monocyte tissue factor gene expression in healthy volunteers , 2004, Thrombosis and Haemostasis.

[4]  C. Esmon.  Inflammation and thrombosis , 2003, Journal of thrombosis and haemostasis : JTH.

[5]  M. Sunamori,et al.  Remaining procoagulant property of wound blood washed by a cell-saving device. , 2001, Annals of Thoracic Surgery.

[6]  J. Levy,et al.  Aprotinin and the systemic inflammatory response after cardiopulmonary bypass. , 2001, The Annals of thoracic surgery.

[7]  D. Arveiler,et al.  Polymorphisms in the 5' regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Témoins de l'Infarctus du Myocarde. Paris Thrombosis case-control Study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[8]  M. Levi,et al.  The Pathophysiology of Disseminated Intravascular Coagulation , 1999, Thrombosis and Haemostasis.

[9]  G. Cirino,et al.  Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk. , 1998, Life sciences.

[10]  G. Schmitz,et al.  Predictors of blood loss after coronary artery bypass grafting. , 1997, Journal of cardiothoracic and vascular anesthesia.

[11]  S. Gando,et al.  Massive Fibrin Formation with Consecutive Impairment of Fibrinolysis in Patients with Out-of-Hospital Cardiac Arrest , 1997, Thrombosis and Haemostasis.

[12]  S. Bélisle,et al.  Hemorrhage and the use of blood products after adult cardiac operations: myths and realities. , 1996, The Annals of thoracic surgery.

[13]  R. Colman,et al.  Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. , 1996, Circulation.

[14]  C. Hogue,et al.  Factors Associated with Excessive Postoperative Blood Loss and Hemostatic Transfusion Requirements: A Multivariate Analysis in Cardiac Surgical Patients , 1996, Anesthesia and analgesia.

[15]  A. Kolstø,et al.  Cell biology of tissue factor, the principal initiator of blood coagulation. , 1996, Thrombosis research.

[16]  R. P. Cochran,et al.  Individual Variations in the Fibrinolytic Response During and After Cardiopulmonary Bypass , 1995, Thrombosis and Haemostasis.

[17]  T. Edgington,et al.  Structural biology of tissue factor, the initiator of thrombogenesis in vivo 1 , 1994, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  H. Philippou,et al.  Mechanisms of thrombin generation during surgery and cardiopulmonary bypass [see comments] , 1993 .

[19]  M. Carrier,et al.  The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases , 1991, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[20]  N. Mackman,et al.  Complete sequence of the human tissue factor gene, a highly regulated cellular receptor that initiates the coagulation protease cascade. , 1989, Biochemistry.

[21]  D. Loskutoff,et al.  Fibrinolytic System of Vascular Endothelial Cells , 1988 .

[22]  S. Sommers,et al.  Disseminated intravascular coagulation following cardiac arrest: a study of 15 patients , 1972, American Journal of the Medical Sciences.